DJ, P., P, D., GG, B., M, N., F, A., C, K., . . . M, N. (2023). BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine. IScience, 26(9), 107612. https://doi.org/10.1016/j.isci.2023.107612
Chicago Style (17th ed.) CitationDJ, Perera, et al. "BCG Administration Promotes the Long-term Protection Afforded by a Single-dose Intranasal Adenovirus-based SARS-CoV-2 Vaccine." IScience 26, no. 9 (2023): 107612. https://doi.org/10.1016/j.isci.2023.107612.
MLA (9th ed.) CitationDJ, Perera, et al. "BCG Administration Promotes the Long-term Protection Afforded by a Single-dose Intranasal Adenovirus-based SARS-CoV-2 Vaccine." IScience, vol. 26, no. 9, 2023, p. 107612, https://doi.org/10.1016/j.isci.2023.107612.